FXTAS presents with upregulation of the cytokines IL12 and TNFα

被引:9
|
作者
Dufour, Brett D. [1 ,2 ,3 ]
Amina, Sarwat [1 ,4 ]
Martinez-Cerdeno, Veronica [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Sacramento, CA USA
[2] Inst Pediat Regenerat Med, Sacramento, CA USA
[3] Shriners Hosp Children Northern Calif, Sacramento, CA USA
[4] Univ Calif Davis, Med Invest Neurodev Disorders MIND Inst, Sacramento, CA 95817 USA
关键词
FXTAS; FMR1; gene; Premutation; Neurodegeneration; TREMOR/ATAXIA SYNDROME; CNS;
D O I
10.1016/j.parkreldis.2020.11.026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Fragile X Tremor and Ataxia Syndrome is a progressive neurodegenerative disorder that develops in some FMR1 premutation carriers. The objective of this study is to characterize how cytokine levels are altered in the FXTAS brain. Methods: Fresh frozen cerebellar tissue from FXTAS cases and controls was homogenized and analyzed for 12 different cytokines using a commercially available ELISA panel. Results: Relative to controls, FXTAS cases showed large and significant increases in the cytokines IL-12 and TNF alpha. There were large but non-significant increases in the levels of IL-2, IL-8, and IL-10 in FXTAS cases. The cytokines IL-1A, IL-1B, IL-4 IL-6, IL-17A, IFN gamma, and GM-CSF were not different between FXTAS and control subjects. Conclusions: For the first time, we demonstrate an increase in the pro-inflammatory cytokines TNF alpha and IL-12 in the FXTAS brain, both of which are implicated in the pathogenesis of Multiple Sclerosis, another neurodegenerative disorder that predominantly consists of white matter disease.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 50 条
  • [21] AUTOANTIBODIES IN PATIENTS WITH IL12 β1 RECEPTOR DEFICIENCY
    Ronca, Vincenzo
    Chen, Qu Bo
    Lygoura, Vasiliky
    Ben-Mustapha, Imen
    Shums, Zakera
    Trifa, Mehdi
    Carbone, Marco
    Mancuso, Clara
    Milani, Chiara
    Bernuzzi, Francesca
    Ma, Xiong
    Agrebi, Nourhen
    Norman, Gary L.
    Chang, Christopher
    Gershwin, M. Eric
    Invernizzi, Pietro
    HEPATOLOGY, 2019, 70 : 868A - 869A
  • [22] Role of IL12 in allergic asthma and inflammation.
    Reinach, AJ
    Zangrilli, JG
    Lustine, HT
    Colavita, AM
    Hastie, AT
    Pollice, M
    Fish, JE
    Peters, SP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A255 - A255
  • [23] IL12 and the human immune response to mycobacteria - Reply
    Modlin
    Barnes
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 531 - 531
  • [24] Cytokines (IFNs, TNF-α, IL-2 and IL-12) and animal models of cancer
    Burke, F
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1999, 5 (01) : 51 - 61
  • [25] IL12, a direct stimulator and indirect inhibitor of haematopoiesis
    Jacobsen, SEW
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 506 - 513
  • [26] Granulomatous lymphadenitis revealing a deficiency in receptor IL12
    Kamoun, Fatma
    Sfaihi, Lamia
    Ben Mustapha, Imen
    Ben Ameur, Salma
    Barbouche, Mohamed Ridha
    Hachicha, Mongia
    PRESSE MEDICALE, 2017, 46 (03): : 346 - 348
  • [27] IL12/IL23 Inhibition in the Treatment of Psoriatic Arthritis
    Mahta Mortezavi
    Christopher Ritchlin
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 197 - 209
  • [28] Management of severe psoriasis with IL12/23 antagonist after development of tnf antagonist-induced lupus
    Vilkaite, A.
    Kucinskiene, V.
    Valiukeviciene, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 43 - 43
  • [29] IL12 in acute viral infectious disease - Commentary
    Romagnani
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 598 - 598
  • [30] Role of IL12 in HIV disease AIDS - Commentary
    Romagnani, S
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 620 - 621